Last 7 days
3.8%
Last 30 days
63.9%
Last 90 days
9.9%
Trailing 12 Months
193.8%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2021 | 2.6M | 1.5M | 743.0K | 0 |
2020 | 9.9M | 8.1M | 6.1M | 4.3M |
2019 | 10.0M | 11.8M | 11.8M | 11.0M |
2018 | 1.2M | 2.3M | 4.9M | 7.7M |
2017 | 0 | 0 | 0 | 558.0K |
2016 | 0 | 0 | 0 | 0 |
2015 | 0 | 0 | 0 | 0 |
2014 | 0 | 0 | 0 | 0 |
2013 | 0 | 0 | 0 | 0 |
2012 | 0 | 0 | 0 | 0 |
2011 | 12.4M | 9.9M | 8.2M | 7.6M |
2010 | 111.9M | 79.5M | 47.2M | 14.8M |
2009 | 0 | 0 | 0 | 144.2M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Nov 21, 2023 | baker bros. advisors lp | bought | 12,128,300 | 188 | 64,350 | - |
Nov 20, 2023 | huntsman carole | acquired | - | - | 7,834 | chief commercial officer |
Nov 20, 2023 | baker bros. advisors lp | bought | 3,846,580 | 185 | 20,709 | - |
Nov 17, 2023 | baker bros. advisors lp | bought | 8,100,700 | 174 | 46,370 | - |
Nov 15, 2023 | baker bros. advisors lp | bought | 2,461,720 | 161 | 15,199 | - |
Nov 14, 2023 | baker bros. advisors lp | bought | 5,799,650 | 154 | 37,660 | - |
Nov 14, 2023 | baker bros. advisors lp | bought | 5,347,840 | 156 | 34,188 | - |
Nov 13, 2023 | baker bros. advisors lp | bought | 10,001,400 | 143 | 69,839 | - |
Sep 11, 2023 | sibold william john | acquired | - | - | 50,000 | president and ceo |
Jun 15, 2023 | daly james m | acquired | - | - | 1,198 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Nov 24, 2023 | DEUTSCHE BANK AG\ | added | 18.47 | -2,147,240 | 6,406,920 | -% |
Nov 22, 2023 | Verity Asset Management, Inc. | added | 36.67 | -61,737 | 392,409 | 0.29% |
Nov 21, 2023 | COMERICA BANK | new | - | 4,131 | 4,131 | -% |
Nov 16, 2023 | McIlrath & Eck, LLC | unchanged | - | -4,418 | 7,594 | -% |
Nov 16, 2023 | Creative Planning | new | - | 302,887 | 302,887 | -% |
Nov 15, 2023 | Tudor Investment Corp Et Al | added | 45.76 | -58,369 | 685,220 | 0.01% |
Nov 15, 2023 | Edgestream Partners, L.P. | reduced | -39.03 | -364,825 | 228,845 | 0.02% |
Nov 15, 2023 | Dana Investment Advisors, Inc. | new | - | 444,984 | 444,984 | 0.02% |
Nov 15, 2023 | Capital Impact Advisors, LLC | unchanged | - | -181,729 | 312,380 | 0.52% |
Nov 15, 2023 | JANE STREET GROUP, LLC | added | 157 | 5,806,980 | 15,098,500 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Nov 21, 2023 | baker bros. advisors lp | 9.99% | 1,987,702 | SC 13D/A | |
Nov 13, 2023 | paulson & co. inc. | 5.1% | - | SC 13G | |
Oct 10, 2023 | janus henderson group plc | 15.4% | 3,042,661 | SC 13G/A | |
Oct 05, 2023 | baker bros. advisors lp | 9.99% | 2,015,760 | SC 13D/A | |
Sep 08, 2023 | janus henderson group plc | 10.3% | 1,910,301 | SC 13G | |
Aug 08, 2023 | baker bros. advisors lp | 8.4% | 1,545,113 | SC 13D/A | |
Jun 20, 2023 | baker bros. advisors lp | 8.4% | 1,545,113 | SC 13D | |
Feb 14, 2023 | baker bros. advisors lp | 9.0% | 1,545,113 | SC 13G/A | |
Feb 14, 2023 | avoro capital advisors llc | 9.7% | 1,660,000 | SC 13G/A | |
Feb 14, 2023 | deep track capital, lp | 0% | 0 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Nov 22, 2023 | 3 | Insider Trading | |
Nov 22, 2023 | 4 | Insider Trading | |
Nov 21, 2023 | 4 | Insider Trading | |
Nov 21, 2023 | 4 | Insider Trading | |
Nov 21, 2023 | SC 13D/A | 13D - Major Acquisition | |
Nov 15, 2023 | 4 | Insider Trading | |
Nov 15, 2023 | 4 | Insider Trading | |
Nov 13, 2023 | SC 13G | Major Ownership Report | |
Nov 06, 2023 | 10-Q | Quarterly Report | |
Nov 06, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
HILS | 32.8B | - | 14.55% | 467931.97% | -3.8K | 218.4K | - | -102.45% |
MRNA | 29.6B | 10.7B | 8.07% | -55.95% | -8.54 | 2.78 | -53.67% | -129.46% |
ALNY | 20.0B | 1.7B | 4.90% | -25.16% | -39.17 | 11.59 | 79.37% | 56.87% |
BMRN | 16.7B | 2.3B | 9.83% | -8.58% | 113.5 | 7.22 | 15.05% | 75.21% |
INCY | 11.8B | 3.6B | 0.63% | -32.44% | 27.88 | 3.28 | 8.35% | -51.49% |
MID-CAP | ||||||||
APLS | 5.7B | 272.9M | 1.64% | -5.18% | -9.43 | 20.95 | 141.38% | 4.43% |
BBIO | 5.2B | - | 21.89% | 247.20% | -8.88 | 48.33 | 54.84% | -12.96% |
ACAD | 3.6B | 631.9M | 1.65% | 46.39% | -24.37 | 5.74 | 23.54% | 31.53% |
AXSM | 3.1B | 223.4M | 6.77% | 16.65% | -15.53 | 14.03 | - | -26.24% |
ARWR | 3.1B | 256.2M | 21.69% | -2.64% | -16.98 | 12 | 2.51% | -17.66% |
SMALL-CAP | ||||||||
CPRX | 1.5B | 348.4M | 17.40% | -16.91% | 24.23 | 4.31 | 81.69% | -7.29% |
NVAX | 648.3M | 1.0B | -14.02% | -66.99% | -1.18 | 0.62 | -43.15% | 58.48% |
INO | 108.4M | 6.4M | 10.81% | -79.60% | -0.66 | 16.83 | -44.11% | 50.48% |
CRBP | 18.7M | - | -19.00% | 3569.57% | -0.39 | - | - | -13.74% |
IBIO | 8.0M | - | - | -82.21% | -0.12 | - | - | -29.23% |
Income Statement (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 | 2017Q3 | 2017Q2 | 2017Q1 | 2016Q4 | 2016Q3 |
Revenue | -34.1% | 60,000 | 91,000 | 160,000 | 432,000 | 823,000 | 1,204,000 | 1,870,000 | 2,214,000 | 2,766,000 | 3,005,000 | 3,039,000 | 2,979,000 | 2,821,000 | 1,166,000 | 705,000 | 216,000 | 174,000 | 92,000 | 76,000 | 59,000 | 42,000 |
Operating Expenses | 2.3% | 63,160,000 | 61,742,000 | 52,979,000 | 59,555,000 | 58,786,000 | 50,327,000 | 38,005,000 | 29,954,000 | 24,195,000 | 22,704,000 | 18,119,000 | 14,454,000 | 11,333,000 | 7,826,000 | 7,069,000 | 8,911,000 | - | - | - | - | - |
S&GA Expenses | -18.0% | 8,287,000 | 10,110,000 | 7,209,000 | 6,126,000 | 5,494,000 | 5,639,000 | 4,605,000 | 5,044,000 | 4,748,000 | 7,110,000 | 5,746,000 | 5,583,000 | 5,122,000 | 2,717,000 | 1,871,000 | 2,399,000 | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -2.4% | -63,100,000 | -61,651,000 | -52,546,000 | -59,123,000 | -57,963,000 | -49,023,000 | -36,135,000 | -27,740,000 | -21,429,000 | -19,699,000 | -15,080,000 | -11,475,000 | -8,512,000 | -6,460,000 | -6,364,000 | -8,445,000 | - | - | - | - | - |
Net Income Margin | -107.2% | -318 | -153 | -83.49 | -46.72 | -27.96 | -16.68 | -10.65 | -7.62 | -5.74 | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | 2.7% | -45,606,000 | -46,883,000 | -43,473,000 | -54,957,000 | -47,853,000 | -24,265,000 | -30,820,000 | -12,416,000 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | -21.3% | 238 | 302 | 332 | 363 | 159 | 216 | 223 | 273 | 305 | 328 | 310 | 287 | 340 | 388 | 411 | 442 | 456 | 470 | 480 | 485 | 490 |
Current Assets | -21.9% | 235 | 302 | 331 | 361 | 157 | 215 | 221 | 272 | 303 | 326 | 308 | 285 | 338 | 387 | 409 | 440 | 455 | 469 | 478 | 485 | 489 |
Cash Equivalents | -19.6% | 62.00 | 77.00 | 113 | 332 | 59.00 | 53.00 | 42.00 | 36.00 | 49.00 | 34.00 | 44.00 | 54.00 | 109 | 62.00 | 67.00 | 47.00 | 89.00 | 73.00 | 47.00 | 57.00 | 38.00 |
Net PPE | 44.8% | 1.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities | 8.4% | 216 | 199 | 182 | 165 | 148 | 133 | 77.00 | 77.00 | 70.00 | 57.00 | 49.00 | 47.00 | 50.00 | 45.00 | 26.00 | 25.00 | 16.00 | 13.00 | 11.00 | 8.00 | 7.00 |
Current Liabilities | 0.0% | 100 | 100 | 98.00 | 116 | 99.00 | 84.00 | 77.00 | 77.00 | 69.00 | 57.00 | 49.00 | 47.00 | 49.00 | 45.00 | 26.00 | 25.00 | 15.00 | 12.00 | 10.00 | 8.00 | 7.00 |
LT Debt, Non Current | 15.6% | 115 | 99.00 | 84.00 | 49.00 | 49.00 | 49.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -78.5% | 22.00 | 104 | 150 | 197 | 11.00 | 84.00 | 146 | 196 | 235 | 271 | 261 | 240 | 290 | 343 | 385 | 417 | 440 | 457 | 469 | 477 | 483 |
Retained Earnings | -8.8% | -1,224 | -1,125 | -1,039 | -962 | -876 | -795 | -724 | -667 | -602 | -539 | -478 | -425 | -366 | -308 | -259 | -223 | -195 | -174 | -154 | -139 | -127 |
Additional Paid-In Capital | 1.4% | 1,246 | 1,229 | 1,190 | 1,160 | 888 | 880 | 871 | 863 | 838 | 810 | 739 | 665 | 656 | 650 | 644 | 640 | 636 | 631 | 623 | 617 | 611 |
Shares Outstanding | 0.2% | 18.00 | 18.00 | 18.00 | 18.00 | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | 16.00 | 16.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 |
Cashflow (Quarterly) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | -12.8% | -84,920 | -75,310 | -84,067 | -58,515 | -59,069 | -57,360 | -49,913 | -48,051 | -45,556 | -46,881 | -43,429 | -54,947 | -47,850 | -24,258 | -30,506 | -12,282 | -11,324 | -11,540 | -6,478 | -6,265 | -5,238 |
Share Based Compensation | 15.4% | 12,660 | 10,973 | 11,250 | 8,082 | 8,122 | 7,944 | 7,477 | 6,356 | 6,242 | 8,179 | 6,096 | 5,134 | 5,061 | 5,689 | 4,846 | 4,032 | 4,950 | 7,755 | 6,022 | 5,119 | 4,976 |
Cashflow From Investing | 1445.1% | 50,199 | -3,732 | -186,864 | 66,387 | 65,137 | 19,236 | 55,926 | 15,643 | 40,091 | -27,325 | -33,464 | -4,798 | 94,753 | 19,365 | 50,460 | -30,507 | 28,267 | 36,438 | -3,491 | 24,988 | -222,028 |
Cashflow From Financing | -54.4% | 19,580 | 42,930 | 52,690 | 264,337 | - | 49,114 | - | 19,503 | 21,099 | 63,541 | 67,094 | 4,629 | 350 | 109 | - | - | 35.00 | 117 | 83.00 | 610 | 451 |
Condensed Consolidated Statements Of Operations - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Revenues: | ||||
Total revenues | ||||
Operating expenses: | ||||
Research and development | 70,951 | 68,271 | 201,710 | 174,699 |
General and administrative | 27,583 | 12,141 | 61,610 | 33,573 |
Total operating expenses | 98,534 | 80,412 | 263,320 | 208,272 |
Loss from operations | (98,534) | (80,412) | (263,320) | (208,272) |
Interest income | 3,298 | 717 | 10,625 | 1,109 |
Interest expense | (3,504) | (1,502) | (8,741) | (2,282) |
Net loss | $ (98,740) | $ (81,197) | $ (261,436) | $ (209,445) |
Net loss per common share: | ||||
Basic net loss per common share | $ (5.34) | $ (4.75) | $ (14.27) | $ (12.25) |
Diluted net loss per common share | $ (5.34) | $ (4.75) | $ (14.27) | $ (12.25) |
Basic weighted average number of common shares outstanding | 18,476,414 | 17,103,395 | 18,326,154 | 17,103,395 |
Diluted weighted average number of common shares outstanding | 18,476,414 | 17,103,395 | 18,326,154 | 17,103,395 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 62,055 | $ 331,549 |
Marketable securities | 170,296 | 27,225 |
Prepaid expenses and other current assets | 3,118 | 2,595 |
Total current assets | 235,469 | 361,369 |
Property and equipment, net | 659 | 601 |
Right-of-use asset | 1,836 | 602 |
Total assets | 237,964 | 362,572 |
Current liabilities: | ||
Accounts payable | 16,542 | 23,831 |
Accrued expenses | 82,610 | 91,461 |
Lease liability | 513 | 602 |
Total current liabilities | 99,665 | 115,894 |
Long term liabilities: | ||
Loan payable, net of discount | 114,727 | 49,289 |
Lease liability | 1,323 | |
Total long term liabilities | 116,050 | 49,289 |
Total liabilities | 215,715 | 165,183 |
Stockholders' equity: | ||
Preferred stock, par value $0.0001 per share authorized: 5,000,000 shares at September 30, 2023 and December 31, 2022; 2,369,797 and 2,369,797 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively | ||
Common stock, par value $0.0001 per share authorized: 200,000,000 at September 30, 2023 and December 31, 2022; 18,494,192 and 18,102,523 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively | 2 | 2 |
Additional paid-in-capital | 1,246,385 | 1,160,079 |
Accumulated other comprehensive loss | (42) | (32) |
Accumulated deficit | (1,224,096) | (962,660) |
Total stockholders' equity | 22,249 | 197,389 |
Total liabilities and stockholders' equity | $ 237,964 | $ 362,572 |
 WEBSITE | www.madrigalpharma.com |
---|---|
 EMPLOYEES | 92 |